Early Antigen Presentation of Protective HIV-1 KF11Gag and KK10Gag Epitopes from Incoming Viral Particles Facilitates Rapid Recognition of Infected Cells by Specific CD8+ T Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early Antigen Presentation of Protective HIV-1 KF11Gag and KK10Gag Epitopes from Incoming Viral Particles Facilitates Rapid Recognition of Infected Cells by Specific CD8+ T Cells
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 87, Issue 5, Pages 2628-2638
Publisher
American Society for Microbiology
Online
2012-12-20
DOI
10.1128/jvi.02131-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes
- (2012) D. Y. Chen et al. BLOOD
- Immune Correlates of HIV Control
- (2011) J.G. Prado et al. CURRENT MEDICINAL CHEMISTRY
- The PTAP Sequence within the p6 Domain of Human Immunodeficiency Virus Type 1 Gag Regulates Its Ubiquitination and MHC Class I Antigen Presentation
- (2011) S. Hahn et al. JOURNAL OF IMMUNOLOGY
- HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency
- (2011) Torsten Schaller et al. PLoS Pathogens
- Antiviral Activity of Human Immunodeficiency Virus Type 1 Gag-Specific Cytotoxic T Lymphocyte Targeting Is Not Necessarily Intrinsically Superior to Envelope Targeting
- (2010) D. Y. Chen et al. JOURNAL OF VIROLOGY
- Simian Immunodeficiency Virus-Specific CD8+T Cells Recognize Vpr- and Rev-Derived Epitopes Early after Infection
- (2010) Jonah B. Sacha et al. JOURNAL OF VIROLOGY
- Phenotypic and Functional Profile of HIV-Inhibitory CD8 T Cells Elicited by Natural Infection and Heterologous Prime/Boost Vaccination
- (2010) S. A. Freel et al. JOURNAL OF VIROLOGY
- Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+T Cells
- (2010) Rebecca P. Payne et al. JOURNAL OF VIROLOGY
- Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 Infection
- (2010) A. Leslie et al. JOURNAL OF VIROLOGY
- Immunology and the elusive AIDS vaccine
- (2010) Herbert W. Virgin et al. NATURE
- Synchronous infection of SIV and HIV in vitro for virology, immunology and vaccine-related studies
- (2010) Jonah B Sacha et al. Nature Protocols
- Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients
- (2009) Hayley Crawford et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses
- (2009) A. Saez-Cirion et al. JOURNAL OF IMMUNOLOGY
- Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection
- (2009) J. B. Sacha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control
- (2008) A. L. Ferre et al. BLOOD
- Polyfunctional T cell responses are a hallmark of HIV-2 infection
- (2008) Melody G. Duvall et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Differential Antigen Presentation Kinetics of CD8+ T-Cell Epitopes Derived from the Same Viral Protein
- (2008) J. B. Sacha et al. JOURNAL OF VIROLOGY
- Functional Consequences of Human Immunodeficiency Virus Escape from an HLA-B*13-Restricted CD8+ T-Cell Epitope in p1 Gag Protein
- (2008) J. G. Prado et al. JOURNAL OF VIROLOGY
- Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
- (2008) Angel Varela-Rohena et al. NATURE MEDICINE
- Toward an AIDS Vaccine
- (2008) B. D. Walker et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now